This finding suggests that hyperglycaemia and/or its downstream metabolic pathways are crucial in the downregulation of glutamine synthetase observed in DR and that vascular hemodynamic changes secondary to the abnormal autoregulatory response do not affect this enzyme, at least in the early stages of DR. The gene discussed is GLUL; the disease is Hyperglycemia.